Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of brivaracetam add-on therapy for focal-onset seizures in China
CTR20240781Phase 3Active
- Sponsor
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brivaracetam in Focal Onset Epilepsy, Focal onset seizure, sponsored by Zhejiang Huahai Pharmaceutical Co., Ltd.. Started Apr 2024; status: active.
02
Drugs
brivaracetam
03
Conditions
Focal Onset EpilepsyFocal onset seizure
Beyond the preview
Go deeper on CTR20240781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240781.